Health Care/Hospital

Conversational AI leader announces OrbitaASSIST, a digitally reimagined voice-powered, AI-driven virtual health assistant proven to improve patient communication at the bedside

BOSTON and SYDNEY, Nov. 19, 2019 /PRNewswire/ -- Orbita, the provider of healthcare's most powerful conversational AI platform, announced today that it is now offering OrbitaASSIST, an award-winning, voice-enabled, AI-driven bedside virtual health assistant. This market-proven solution offers an...

2019-11-19 21:33 318

Burning Rock Dx Launches Magnis BR to Innovate Total Process Automation for NGS Testing

ZHENGZHOU, Nov. 19, 2019 /PRNewswire/ -- Today, Agilent Technologies and Guangzhou Burning Rock Medical Laboratory Co., Ltd. ("Burning Rock Dx") jointly held a product launch event on Magnis BR, an automated next generation sequencing (NGS) library preparation system, to announce that Magnis BR i...

2019-11-19 21:00 346

Edan to Highlight Its New Developments at MEDICA 2019

DUSSELDORF, Germany, Nov. 19, 2019 /PRNewswire/ -- Edan, a healthcare solutions provider, revealed their latest product series in its all five product lines, including Obstetrics and Gynecology, Patient Monitoring, In-Vitro Diagnostics, Diagnostic ECG, and Ultrasound, bringing a huge surprise to ...

2019-11-19 18:18 171

ABL Bio Inc.- GenScript Biotech Corp Bispecific Antibody Strategic Partnership Agreement Ceremony

NANJING, China and SEOUL, South Korea, Nov. 18, 2019 /PRNewswire/ -- GenScript Biologics, a world leading bio-pharmaceutical CDMO company, announced today that it entered into an agreement with ABL Bio Inc., a South Korean biotech company dedicated to therapeutics for immuno-oncology and neurodeg...

2019-11-18 22:00 289

Plant Nanny 2, the Self-care Water Consumption Reminding app Has Been Nominated for "Google Play Best of 2019" Launches Brand New Version 2.0

TAIPEI, Nov. 18, 2019 /PRNewswire/ -- About 70% of human body is composed of water. However, according to the Quench Survey, nearly 80% of working Americans say they don't drink enough water. Keeping hydrated is crucial for a person's health and well-being, but there is a substantial amount of pe...

2019-11-18 14:30 200

Yili launches "Yili Future Intelligence and Health Valley" to promote health industry dev.

BEIJING, Nov. 17, 2019 /PRNewswire/ -- China's dairy giant Inner Mongolia Yili Industrial Group on Sunday launched the project of "Yili Future Intelligence and Health Valley" in Hohhot, capital of northChina's Inner Mongolia Autonomous Region, striving for boosting the health industry in the regi...

2019-11-18 12:05 292

3SBio Selects Verseau's PSGL-1-targeted Antibody VTX-0811 as First Partnered Macrophage Checkpoint Modulator in Immuno-Oncology Collaboration

SHENYANG, China and BEDFORD Mass., Nov. 17, 2019 /PRNewswire/ -- 3SBio Inc. ("3SBio") (HKEX:1530) and Verseau Therapeutics, Inc.  ("Verseau") today announced the selection of VTX-0811, a monoclonal antibody targeting PSGL-1, as the first lice...

2019-11-18 08:30 1745

China Pharma Holdings, Inc. Reports Third Quarter 2019 Financial Results

HAIKOU CITY, China, Nov. 15, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the qu...

2019-11-15 21:00 4295

Viva Biotech Partnership Summit Successfully Launched in Shanghai

SHANGHAI, Nov. 15, 2019 /PRNewswire/ -- 2019 Viva Biotech Partnership Summit (the "Summit") was successfully launched on8 November 2019 in Pudong, Shanghai, themed "Innovation Partnership Growth". Founders from over 30 global innovative and biopharmaceutical companies incubated/ invested by Viva ...

2019-11-15 14:16 411

I-Mab Biopharma Receives IND Approval from NMPA to Initiate Clinical Trials for its Anti-GM-CSF Monoclonal Antibody TJM2 in China

SHANGHAI, Nov. 14, 2019 /PRNewswire/ -- I-Mab Biopharma ("I-Mab"), a China and U.S.-based clinical-stage biopharmaceutical company exclusively focused on the discovery and development of novel or highly differentiated biologics in immuno-oncology and autoimmune diseases today announced that Natio...

2019-11-14 23:45 388

China Jo-Jo Drugstores Reports Second Quarter 2020 Financial Results

HANGZHOU, China, Nov. 14, 2019 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a provider of healthcare services inChina, today a...

2019-11-14 22:00 4387

DOF ranks 1st in Korea Brand Preference Award for three consecutive years

SEOUL, South Korea, Nov. 14, 2019 /PRNewswire/ -- The global dental medical device brand DOF took the first place in the Korea Brand Preference Award (in the dental medical device section) for three consecutive years, at the ceremony held in the Riverside Hotel in Gangnam,Seoul, on the 22nd. Sp...

2019-11-14 21:00 230

Samsung Biologics Enhances Its Trusted Service as the First and Only ISO27001 Certified CDMO

INCHEON, South Korea, Nov. 14, 2019 /PRNewswire/ -- Samsung Biologics announced that it has obtained ISO 27001 certification, the most prestigious international standard on information security management. Samsung Biologics is the first CDMO company to be ISO 27001 certified globally. A ceremony...

2019-11-14 20:00 206

111, Inc. Announces Third Quarter 2019 Unaudited Financial Results

SHANGHAI, Nov. 14, 2019 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading integrated online and offline healthcare platform in China, today announced its unaudited financial results for the third quarter endedSeptember 30, 2019.  Third Quarter 2019 Highlights * Net rev...

2019-11-14 17:56 4416

111 Signs Strategic Partnership with HEC Group to Strengthen Cooperation with Innovative Pharmaceutical Manufacturer

SHANGHAI, Nov. 14, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, announced today that it will establish an integrated online and offline healthcare retail channel with HEC Group ("HEC"). The channel will be used ...

2019-11-14 16:35 4410

China Biologic Reports Financial Results for the Third Quarter of 2019

BEIJING, Nov. 13, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced its unaudited financial results for the third quarter of 2019. Third Quarter...

2019-11-14 05:43 4815

VolitionRx Limited Announces Third Quarter 2019 Financial Results and Business Update

AUSTIN, Texas, Nov 13, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the third quarter endedSeptember 30, 2019. Volition management will host a conference call tomorrow,November 13, at 8:30 a.m. U.S. Eastern ...

2019-11-13 16:54 4702

Stone Street Group Initiates Coverage On BiomX Inc.

NEW YORK, Nov. 12, 2019 /PRNewswire/ -- Stone Street Group has announced it has initiated coverage on BiomX Inc (NYSE: PHGE). The full report can be found here: PHGE Report Ke...

2019-11-12 20:25 300

TenNor Therapeutics Reported Phase II Top-Line Results for TNP-2092

SUZHOU, China, Nov. 11, 2019 /PRNewswire/ -- TenNor Therapeutics reported positive top-line results for TNP-2092 powder for injection from a phase II clinical trial conducted inthe United States. TNP-2092 is currently under clinical development for the treatment ofprosthetic joint infections and ...

2019-11-11 21:00 330

Akesobio Presents Phase 1 Clinical Data from First-in-class Bispecific Drug Candidate AK104 (PD1/CTLA4) As Oral Presentation, at 2019 SITC Annual Meeting

NATIONAL HARBOR, Md., Nov. 11, 2019 /PRNewswire/ -- Akeso Biopharma ("Akeso") presented results of phase 1 study of its first-in-class bispecific drug candidate  AK104, in patients with advanced solid tumors in 2019 Society for Immunotherapy of Cancer ("SITC"). AK104 is a novel, tetrameric bispec...

2019-11-11 17:35 245
12345 ... 531